You just read:

MeiraGTx Receives Rare Pediatric Disease Designation for A001 for the Treatment of Leber's Congenital Amaurosis and Treats First Pediatric Patient in Phase 1/2 Clinical Trial

News provided by

MeiraGTx

Dec 07, 2017, 08:30 ET